PRiME Seminars in AI and Drug Discovery
💊 PRiME Seminars in AI and Drug Discovery
🚀 Unlocking the Future of Therapeutics
Join us for the next session in our newly launched seminar series exploring how artificial intelligence is transforming drug discovery. From molecular design to clinical prediction, each session brings leading researchers, innovators, and industry experts to share cutting edge insights.
📅 When
Wednesday, April 29, 2026
3-4 pm
📍 Where
Leslie Dan Faculty of Pharmacy
Room 850, 8th floor
144 College St.
University of Toronto
🎤 Upcoming Speaker
Professor Teresa Head-Gordon
University Endowed Chair in Computational Science
Departments of Chemistry, Bioengineering, Chemical and Molecular Bioengineering
University of California, Berkeley
“Machine Learning Foundations and Large Language Models are Here for In Silico Drug Discovery”
Teresa Head-Gordon is a leader in theoretical chemistry and biophysics, creating methodological advances at the interface between quantum and statistical mechanics, and AI and machine learning. Her fundamental work includes theory and methods to understand water and aqueous solvation, molecular interactions, interfaces, chemical reactivity and (bio)catalysis, drug discovery, and protein biophysics with notable impacts on energy, environment, and human health applications. She is Director of CalSolv at UC Berkeley, a Co-Director of the National Molecular Sciences Software Institute; current or previous editorial Advisory Board Member of Journal of Chemical Physics, Journal of Physical Chemistry; Journal of Computational Chemistry; and SIAM book series on Computational Science and Engineering. She led the creation of the COVID-19 Hub in April 2020, connecting scientists across the global molecular simulation community to create and house extensive data sets, to organize a deep dive into the SARS-COV-2 biology, and enabling tools to accelerate drug discovery, while establishing partnerships with CERN, Amazon, Microsoft's AI for Good team, and Human Brain Initiative to advance the science. Her leadership contributions to local and national service, education, and training, extends to promoting and developing the blueprint for computational science and engineering for the future. She created the Professional Master's in Molecular Science and Software Engineering (MSSE) degree at UC Berkeley, joint between the College of Chemistry and College of Engineering, with special emphasis on leadership in computational science and software engineering. She also co-led the expansion of research opportunities for junior transfer students via the Berkeley Collegium program, to promote them for participation in STEM fields. Nationally, she has taken on many leadership and advisory roles for various directorates within NIH, DOE, NSF, and NAS panels for computational science and engineering, as well internationally by serving on scientific decision bodies in Europe. Honors include IBM SUR award; Schlumberger Fellow, Cambridge University, UK; Fellow, AIMBE; Fellow, ACS; Fellow, ReSolv German Center of Excellence, and recipient of the Humboldt Research Award. She has given multiple public and citizen lectures in the US and Europe on the Ethics of Emerging Technologies: The Era of Artificial Intelligence, a lecture taken from her popular ethics course at UC Berkeley.
🔗 Registration & Details
Everyone is welcome to attend.
Graduate students interested in having their attendance at these seminars on their transcript can sign up for the seminar course PHM3100 (0.13 FCE: CR/NCR). All students are welcome to join, but since the deadline for registration has passed, request access to the course using the Course Add/Drop form that you submit to your grad program coordinator.
Hybrid available on demand. Link will be provided upon request, please contact [email protected].
For more information, please contact organizer:
Carolyn Cummins, PhD
Associate Professor, Pharmaceutical Sciences